General Information
UEMS CME Accreditation

We are pleased to inform you that all 6 LCS webinars 2021 have been granted 1 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).
The certificate of attendance/CME certificate will be sent 1 month after the live webinar.

 

Recommended Bandwidth

The website www.speedtest.net offers you to check your bandwidth. We strongly recommend
• Upload min. 6Mbit required bandwidth (relevant for speakers, moderators sharing their camera and audio signal)
• Download min. 6Mbit required bandwidth
Also, we recommend a cable internet or a wireless connection with full signal.
Please note: Shared bandwidth (e.g. hospital, universities) will result in lower bandwidth for each user.

 

The webinars are open for

– all interested persons
– persons who have actively subscribed for the LCS certification (Step 1 of the programme outline)

Exclusive Sponsor 2021
THANK YOU

We cordially thank our industry partner Siemens Healthineers for their valuable support of the ESTI LCS Webinars 2021.

Monday, October 25, 2021 | 18:00 CEST
Technical requirements for LCS: How to perform the acquisition (dose, slice thickness), How to read the scans
Speaker: Annemiek Snoeckx, Edegem/BE | Moderator: Thomas Frauenfelder, Zurich/CH

  

Description:
This webinar discusses the technical requirements for low-dose CT for lung cancer screening. Following items will be discussed: the importance of low radiation dose for screening, radiation dose in some of the large lung cancer screening trials, volumetric measurement, technical standards for lung cancer screening as proposed by ESTI, role of the radiologist, how LCS scans should be read.

Learning objectives:
After listening to the webinar, you will
– have gained insight in the importance of low dose CT in lung cancer screening
– have learned about the radiation dose in some of the large lung cancer screening trials
– be updated with the technical standards for lung cancer screening as proposed by ESTI
– be informed on how lung cancer screening scans should be read
– have gained insight about the latest evidence on radiation dose in LCS

Monday, November 15, 2021 | 18:00 CET
Solid nodule morphological evaluation: How to recognise obviously benign/malignant nodules, how to recognise intrapulmonary lymph nodes, pitfalls
Speaker: Anand Devaraj, London/UK | Moderator: Mario Silva, Parma/IT

 

Description:
This webinar will illustrate and discuss the crucial morphological features of solid lung nodules that help differentiate benign and malignant nodules and how they impact on management in screening

Learning objectives:
– Understand that lung nodule management is determined mainly by nodule size and morphology
– Learn the key features of benign intrapulmonary lymph nodes
– Understand the appearances and management of inflammatory lesions
– Be aware of the CT morphological appearances of atypical lung cancers

Monday, December 06, 2021 | 18:00 CET
Solid nodule measurement and follow‐up, criteria of positive screens
Speaker: Helmut Prosch, Vienna/AT | Moderator: Mario Silva, Parma/IT

 

Learning objectives:
– To become familiar with the pros and cons of 2D and 3D measurements of pulmonary nodules
– To understand the importance of module management protocols in lung cancer screening

Monday, January 17, 2022 | 18:00 CET
Subsolid nodules evaluation and follow-up, criteria of positive screens
Speaker: Marie-Pierre Revel, Paris/FR | Moderator: Mario Silva, Parma/IT

 
   

Learning objectives:
– To learn how to distinguish between pure ground glass and part-solid nodules
– To learn about the correlations between CT features and histopathology
– To learn about the criteria defining positive screen results and growth during follow-up
– To understand the importance of long term surveillance for non-resected subsolid nodules
– To be aware of the risk of overdiagnosis and overtreatment of subsolid nodules

Monday, February 21, 2022 | 18:00 CET
Comorbidities and incidentals findings in lung cancer screening CT
Speaker: Hans-Ulrich Kauczor, Heidelberg/DE | Moderator: Mario Silva, Parma/IT

 
   

Description
Webinar 6 discusses the rationale for reporting comorbidities and incidental findings on low-dose CT for lung cancer screening. The following comorbidities and incidentals will be presented: cardiovascular disease (coronary and extracoronary calcifications), COPD (airway abnormalities and emphysema), interstitial lung disease, extrapulmonary masses, osteopenia and osteoporosis, structured reporting for ancillary findings.

Learning objectives:
After listening to the webinar, you will
– have gained insight in the rationale of comorbidities and incidental findings of low dose CT in lung cancer screening
– have learnt about the significance of cardiovascular disease for mortality in the LCS population
– have consolidated knowledge about incidentals as being actionable, reportable and not-reportable
– be aware of potential harms: anxiety, cost and additional morbidity

Active members have access to the LCS webinar recordings below (after a period of approximately 30 days). Please login either at the right upper corner or by clicking on the respective video. If the access has been denied, please contact office@myESTI.org to check your membership status.

X